• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Scotts Miracle Gro (SMG) Stock Still Offers A Discount After A 59% Slide

    Simply Wall St·10/01/2026 22:27:04
    Listen to the news

    Scotts Miracle-Gro has seen its share price fall sharply over the past several years, which naturally raises a question for anyone looking at the stock today. Are the cash flows this business can realistically produce enough to support where the market is now pricing it?

    • The share price has fallen 58.9% over the past 5 years, so the valuation question today is whether that drop already reflects the cash flow profile of the business.
    • For a company built around consumer lawn and garden products, the key driver for valuation can be how effectively it turns seasonal demand into consistent cash generation that covers investment needs and debt obligations.
    • What if you looked at Scotts Miracle-Gro through its earnings instead? See why Scotts Miracle-Gro's 18.8x P/E tells a different valuation story.

    The issue now is whether the current US$50.02 share price is in line with the cash flows implied by the intrinsic value estimate based on its Discounted Cash Flow (DCF) model.

    If you are weighing whether Scotts Miracle-Gro’s cash flows justify today’s valuation, it can help to compare that picture with 27 high quality undervalued stocks.

    Does Scotts Miracle-Gro Look Undervalued on Cash Flow?

    The Discounted Cash Flow (DCF) approach here is built around the cash the business can return to shareholders over time. Scotts Miracle-Gro generated roughly $280.35 million of free cash flow over the last twelve months, and the model expects that figure to stay in the same ballpark, with modest growth rather than big step changes.

    Projected free cash flows through the early 2030s are estimated to trend gradually higher in dollar terms, then level into a steadier phase. This pattern is typical of a mature consumer brand rather than a high growth story. When those future cash flows are discounted back and compared with today’s US$50.02 share price, the DCF output points to an estimated intrinsic value that is substantially above where the stock trades now. That gap is what the detailed model behind this summary is designed to help you explore in more depth. Find out what Scotts Miracle-Gro could be worth using our Discounted Cash Flow (DCF) estimate.

    The Scotts Miracle-Gro Narrative: What Would Justify Today's Price?

    Simply Wall St Narratives pick up where the DCF puzzle leaves off for Scotts Miracle-Gro by spelling out which paths for growth, margins and earnings would need to occur for the shares to be worth materially more or less than today’s price on the Community page. Each scenario ties a fair value to a specific mix of potential catalysts and risks, which gives you a reference point to see over time which version of the story is actually unfolding.

    Community views on Scotts Miracle-Gro split between a margin recovery and brand mix story on one side and a cultivation risk overhang on the other.

    Bull case: 37% undervalued

    "Ongoing cost savings and automation in the supply chain, with over US$100 million in cost reductions already captured toward a US$180 million target..."

    Discover why this Narrative puts Scotts Miracle-Gro at 37% undervalued.

    Bear case: 15% overvalued

    "Pandemic-era demand spikes, followed by normalization and channel inventory corrections, weighed heavily on results and investor sentiment..."

    Explore why this Narrative puts Scotts Miracle-Gro at 15% overvalued.

    The Scotts Miracle-Gro price is only one piece of the decision

    Valuation work tells you what you might be paying for Scotts Miracle-Gro, but our broader checks also flag potential pressure points that deserve a closer look before you commit. Take a closer look at 3 warning signs (1 major) before settling on a valuation.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.